Gasior, Maria
At the time of the study, Shire Development LLC, Lexington, Massachusetts7Now with BTG International, Philadelphia, Pennsylvania.
13 papers on CoChat
Most cited papers
- Verified
Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial
McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015) · JAMA Psychiatry
Eating Disorders and BehaviorsPharmacology and Obesity Treatment
Cited by 322
- Verified
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
McElroy, S. L., Hudson, J., Ferreira-Cornwell, M. C., Radewonuk, J., Whitaker, T., & Gasior, M. (2016) · Neuropsychopharmacology
Eating Disorders and BehaviorsPharmacology and Obesity Treatment
Cited by 254
- Verified
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
Bernhardt, J., Churilov, L., Ellery, F., Collier, J., Chamberlain, J., Langhorne, P., Lindley, R. I., Moodie, M., Dewey, H., Thrift, A. G., et al. (2016) · Neurology
Stroke Rehabilitation and RecoveryAcute Ischemic Stroke Management
Cited by 221
- Verified
Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial
Hudson, J. I., McElroy, S. L., Ferreira-Cornwell, M. C., Radewonuk, J., & Gasior, M. (2017) · JAMA Psychiatry
Eating Disorders and BehaviorsPharmacology and Obesity Treatment
Cited by 158
- Verified
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design
Wigal, T., Brams, M., Gasior, M., Gao, J., Squires, L., Giblin, J., & 316 Study Group (2010) · Behavioral and Brain Functions
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 136
- Verified
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Childress, A. C., Cutler, A. J., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Squires, L. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 120
- Verified
Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design
Brams, M., Weisler, R., Findling, R. L., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Squires, L. (2012) · The Journal of Clinical Psychiatry
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 41
- Verified
A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Findling, R. L., Cutler, A. J., Saylor, K., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Childress, A. C. (2013) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 40
- Verified
Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults
Brown, T. E., Brams, M., Gao, J., Gasior, M., & Childress, A. (2010) · Postgraduate Medicine
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 29
- Verified
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults
Brown, T. E., Brams, M., Gasior, M., Adeyi, B., Babcock, T., Dirks, B., Scheckner, B., & Wigal, T. (2011) · Current Medical Research and Opinion
Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment
Cited by 24
- Verified
Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
Wigal, T., Brams, M., Gasior, M., Gao, J., & Giblin, J. (2011) · Postgraduate Medicine
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 17
- Verified
Effects of Open-Label Lisdexamfetamine Dimesylate on Self-Reported Quality of Life in Adults with ADHD
Brams, M., Giblin, J., Gasior, M., Gao, J., & Wigal, T. (2011) · Postgraduate Medicine
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 15
- Verified
Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder
Childress, A. C., Cutler, A. J., Saylor, K., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Findling, R. L. (2014) · Journal of Child and Adolescent Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free